SPHD-400

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSPHD-400
Drug Alias NameSPHD-400
ClassificationSmall molecules
Mechanisms of ActionLeukocyte elastase inhibitorsCytokine receptors antagonists
TargetsCytokine receptorsLeukocyte elastase
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesSinclair Pharma PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinclair Pharma PLC
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A